Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue12¢$160.2K
- Research and development23¢$301.9K
- Interest65¢$844.9K
Out of $214.6K in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $04 | $05 | $58.1K6 | $489.2K7 | $93.7K8 | $265.7K3 | $214.6K3 |
| Cost of revenue | $04 | $05 | $33.9K6 | $387.2K7 | $43.8K8 | $182.5K3 | $160.2K3 |
| Gross profit | $04 | $05 | $24.2K6 | $102.0K7 | $49.9K8 | $83.2K3 | $54.3K3 |
| Research and development | $289.6K5 | $210.2K6 | $103.6K7 | $210.7K8 | $329.5K3 | $301.9K3 | |
| Operating expenses | $8.7M3 | $9.7M3 | |||||
| Operating income | -$90.5K4 | -$905.2K5 | -$1.3M6 | -$970.2K7 | -$2.8M8 | -$8.7M3 | -$9.6M3 |
| Interest | $2384 | $97.7K5 | $159.2K6 | $32.9K6 | $29.5K8 | $467.8K3 | $844.9K3 |
| Income before tax | -$9.1M3 | -$12.3M3 | |||||
| Income tax | $04 | $05 | $05 | $2.2K7 | |||
| Net income | -$90.7K4 | -$958.3K5 | -$1.4M6 | -$1.0M7 | -$2.8M8 | -$9.1M3 | -$12.3M3 |
| Earnings per share | -$0.108 | -$25.043 | -$12.953 | ||||
| Earnings per share (diluted) | -$25.043 | -$12.953 | |||||
| Shares (weighted, basic) | 363.5K shares3 | 953.3K shares3 | |||||
| Shares (weighted, diluted) | 363.5K shares3 | 953.3K shares3 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $42.8K5 | $297.5K6 | $163.6K7 | $261.4K7 | $68.9K8 | $785.4K3 | $747.7K3 |
| Receivables | $16.9K3 | $9473 | |||||
| Inventory | $146.1K3 | $149.6K3 | |||||
| Current assets | $3.6K4 | $308.5K5 | $178.1K6 | $289.3K7 | $133.4K8 | $1.1M3 | $1.3M3 |
| Property, plant and equipment | $123.0K3 | $120.9K3 | |||||
| Goodwill | $913.2K3 | ||||||
| Intangible assets | $10.9M3 | $10.2M3 | |||||
| Total assets | $3.6K4 | $310.0K5 | $180.1K6 | $291.0K7 | $225.1K8 | $13.4M3 | $11.7M3 |
| Current liabilities | $84.1K4 | $1.2M5 | $227.0K6 | $1.2M7 | $2.1M8 | $4.3M3 | $7.4M3 |
| Total liabilities | $1.2M5 | $234.1K6 | $1.2M7 | $2.2M8 | $14.1M3 | $7.4M3 | |
| Retained earnings | -$22.3M3 | -$34.6M3 | |||||
| Shareholders’ equity | -$54.5K5 | -$910.7K6 | -$54.0K7 | -$895.5K7 | -$2.0M3 | -$694.9K3 | $4.3M3 |
| Shares outstanding | 10.0M shares4 | 9.9M shares5 | 19.2M shares6 | 19.4M shares7 | 29.5M shares8 | 593.4K shares3 | 1.2M shares3 |
Corporate structure
BRAIN SCIENTIFIC INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of BRAIN SCIENTIFIC INC.
- MANCHESTER MANAGEMENT CO LLC Filed SC 13D on BRAIN SCIENTIFIC INC., latest Aug 4, 2022
- Andrew M. Brown Filed SC 13G/A on BRAIN SCIENTIFIC INC., latest Feb 14, 2022
- Thomas Caleca Filed SC 13G/A on BRAIN SCIENTIFIC INC., latest Feb 14, 2022
- Hassan Kotob Filed SC 13D on BRAIN SCIENTIFIC INC., latest Oct 27, 2021
- BRAIN SCIENTIFIC INC. Lakewood Ranch, Florida
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What BRAIN SCIENTIFIC INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated depreciation | $101.3K3 Dec 31, 2022 | $66.0K3 Dec 31, 2021 | +53.6% |
| Property and equipment, net | $120.9K3 Dec 31, 2022 | $123.0K3 Dec 31, 2021 | −1.7% |
| Operating-lease assets (leased space) | $88.5K3 Dec 31, 2022 | $191.7K3 Dec 31, 2021 | −53.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $747.7K3 Dec 31, 2022 | $785.4K3 Dec 31, 2021 | −4.8% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $913.2K3 Dec 31, 2021 | ||
| Intangible assets, net (excluding goodwill) | $10.2M3 Dec 31, 2022 | $10.9M3 Dec 31, 2021 | −7.0% |
| Finite-lived intangibles, gross | $10.2M3 Dec 31, 2022 | $10.9M3 Dec 31, 2021 | −7.0% |
| Accumulated amortization | $11.1M3 Dec 31, 2022 | $11.1M3 Dec 31, 2021 | 0% |
Inventory
Leadership
Who has led BRAIN SCIENTIFIC INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
- Chief executive officerHassan Kotob Oct 27, 2021 to Aug 22, 202211
- ChairBoris Goldstein Oct 15, 2020 to Oct 15, 202012
- Chief financial officerBonnie-Jeanne Gerety Oct 14, 2021 to Aug 22, 202213
- Chief financial officerMark Corrao Oct 15, 2020 to Oct 15, 202014
Board members and other officers (4)
- Chief Technology OfficerFarid Anthony Apr 28, 2022 to Aug 23, 202215
- Board memberDaniel Danny Cloutier Aug 25, 2022 to Aug 25, 202216
- Board memberHassan Kotob Oct 27, 2021 to Aug 22, 202211
- Board memberDonald S. Mackenzie Nov 16, 2021 to Aug 24, 202217
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
- All Soft Gels IncDec 29, 2015 to Sep 24, 20182
Timeline
- May 3, 20238-K Other events20
- Apr 5, 20238-K Entered a material agreement; Unregistered sale of shares21
- Mar 20, 20238-K Entered a material agreement; Unregistered sale of shares22
- Feb 6, 20238-K Bylaws or fiscal year changed23
- Jan 3, 20238-K Executive or director change24
- Nov 3, 20228-K Executive or director change; Other events25
- Jun 15, 20228-K Entered a material agreement; Unregistered sale of shares; Other events26
- Apr 19, 20228-K Regulation FD disclosure27
- Apr 6, 20228-K Entered a material agreement28
- Feb 16, 20228-K Entered a material agreement; Unregistered sale of shares29
- Feb 8, 20228-K Executive or director change30
- Jan 13, 20228-K Regulation FD disclosure31
- Oct 27, 2021New chief executive Hassan Kotob becomes CEO11
Filings
62 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 18 major events, 24 insider forms, 4 large holders, 2 private raises, 8 other. The latest 20:
- Jan 11, 2024SEC STAFF ACTION EDGAR
- May 5, 202315-12G NOTICE OF TERMINATION OF REGISTRATION EDGAR
- May 3, 20238-K CURRENT REPORT EDGAR
- Apr 5, 20238-K CURRENT REPORT EDGAR
- Mar 31, 202310-K ANNUAL REPORT EDGAR
- Mar 20, 20238-K CURRENT REPORT EDGAR
- Feb 14, 2023S-1/A AMENDMENT NO. 3 TO FORM S-1 EDGAR
- Feb 10, 2023S-1/A AMENDMENT NO. 2 TO FORM S-1 EDGAR
- Feb 6, 20238-K CURRENT REPORT EDGAR
- Jan 18, 2023S-1/A AMENDMENT NO. 1 TO FORM S-1 EDGAR
- Jan 3, 20238-K CURRENT REPORT EDGAR
- Nov 14, 202210-Q QUARTERLY REPORT EDGAR
- Nov 3, 20228-K CURRENT REPORT EDGAR
- Aug 25, 20224 OWNERSHIP DOCUMENT EDGAR
- Aug 25, 20223 OWNERSHIP DOCUMENT EDGAR
- Aug 24, 20224 OWNERSHIP DOCUMENT EDGAR
- Aug 24, 20224 OWNERSHIP DOCUMENT EDGAR
- Aug 24, 20224 OWNERSHIP DOCUMENT EDGAR
- Aug 23, 20224 PRIMARY DOCUMENT EDGAR
- Aug 22, 20224 EDGAR
The 62 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- MANCHESTER MANAGEMENT CO LLCSC 13D, 1 filing Aug 4, 202232
- Andrew M. BrownSC 13G/A, 1 filing Feb 14, 202233
- Thomas CalecaSC 13G/A, 1 filing Feb 14, 202234
- Hassan KotobSC 13D, 1 filing Oct 27, 202135
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $14.8M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2022 | $5.1M | $5.1M |
| 2021 | $9.7M | $9.7M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
SEC filer profile
How BRAIN SCIENTIFIC INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBRAIN SCIENTIFIC INC.1
- CIK0001662382
- Employer ID (EIN)81-08767141
- Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
- Incorporated inNevada1
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address6700 Professional Parkway, Lakewood Ranch, FL 342401
- Phone(646) 388-37881
- Shares outstanding1,242,647 as of Mar 31, 20233
- Public float$7.9M as of Jun 30, 20223
- On EDGAR sinceDec 29, 20151
- Filings227 in all: 8-K (88), 10-Q (21), 4 (17), CORRESP (11), 3 (10), S-1/A (9), UPLOAD (9), 10-K (7)1
All 34 form types
NT 10-Q (7), D (6), 8-K/A (4), SC 13D (4), 1-A/A (3), 10-Q/A (3), EFFECT (3), NT 10-K (3), S-1 (3), SC 13G (2), SC 13G/A (2), 1-A (1), 10-K/A (1), 15-12G (1), 4/A (1), 424B3 (1), 424B4 (1), 8-A12G (1), DEF 14C (1), DEFA14A (1), DEFM14C (1), POS AM (1), PRE 14C (1), PREM14C (1), QUALIF (1), SEC STAFF ACTION (1)
- Latest filingsAnnual report (10-K) Mar 31, 2023
Quarterly report (10-Q) Nov 14, 2022
Latest 8-K (8-K) May 3, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARBoris Goldstein, Chair
- 13
- 14SEC EDGARMark Corrao, Chief financial officer
- 15
- 16SEC EDGARDaniel Danny Cloutier, Board member
- 17SEC EDGARDonald S. Mackenzie, Board member
- 18
- 19
- 20SEC EDGAROther events
- 21
- 22
- 23SEC EDGARBylaws or fiscal year changed
- 24SEC EDGARExecutive or director change
- 25
- 26
- 27SEC EDGARRegulation FD disclosure
- 28SEC EDGAREntered a material agreement
- 29
- 30SEC EDGARExecutive or director change
- 31SEC EDGARRegulation FD disclosure
- 32
- 33
- 34
- 35